Officials at Agilent Technologies, the now independent Massachusetts-based company spun off by computer giant Hewlett Packard, say they are disappointed by the company's latest performance in the healthcare arena.Agilent Technologies is made up of
Officials at Agilent Technologies, the now independent Massachusetts-based company spun off by computer giant Hewlett Packard, say they are disappointed by the company's latest performance in the healthcare arena.
Agilent Technologies is made up of electronics, communications, and healthcare businesses. The company's healthcare products include the Sonos 5500 cardiac ultrasound system, Sonos 4500 digital imaging system, and the ImagePoint multispecialty digital ultrasound system.
In the second quarter of 2000 (end-April 30), the electronics and communications businesses did well, but healthcare did not, said Ned Barnholt, Agilent's president and CEO.
Recently published reports speculating that Agilent will sell off its healthcare business if performance continues to decline are not true, said Heidi Wilson, Agilent spokesperson. Instead, Agilent has plans to restructure the division, she said.
Agilent reported that second quarter 2000 net revenue rose to $2.5 billion, up 24% over second quarter 1999. Net earnings for the quarter rose 6% to $166 million, compared with $157 million in the same quarter last year.
Orders in healthcare during second quarter 2000 were $349 million, down 9% compared with second quarter 1999. There are two factors that slowed the healthcare business, according to the firm: hospital purchases that were recorded in fiscal 1999 to avoid possible Y2K issues and increasing government pressure on hospitals from the balanced budget amendment to keep costs down.
Wilson said the healthcare division's restructuring plans include accelerating product promotions and slowing down noncritical hiring. The results of the changes will be evaluated by top company officials, she said.
"If, in a certain amount of time, a segment of business is not living up to expected results, of course the company will look at its options," Wilson said.
Wilson said there will be an announcement of new product availability at the June 11-14 American Society of Echocardiography meeting in Chicago. In addition, Agilent has signed an agreement to acquire Zymed, an Oxnard, CA-based provider of cardiac analysis solutions.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.